Cipla’s Q1 2026 Profit Jumps Nearly 10%: Steady Growth Despite Pricing Pressures
Cipla Limited, one of India’s largest pharmaceutical companies, has reported a strong financial performance for the first quarter of 2026. The company posted a total revenue of ₹7,216.03 crore, marking a year-on-year (YoY) increase of 5.28%, while net profit rose 9.88% YoY to ₹1,291.61 crore. This performance reflects the company’s solid hold in the domestic…
